Northern Trust’s Ascendis Pharma A/S ASND Stock Holding History

Northern Trust’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.7M	Buy	103,933 +58,962	+131%	+$13.8M	﹤0.01%	1602
2026 Q1	$10.3M	Buy	44,971 +12,117	+37%	+$2.72M	﹤0.01%	2060
2025 Q4	$7.01M	Buy	32,854 +17,297	+111%	+$3.57M	﹤0.01%	2276
2025 Q3	$3.09M	Buy	+15,557	New	+$2.9M	﹤0.01%	2785
2025 Q2	–	Sell	-1,592	Closed	-$248K	–	4408
2025 Q1	$248K	Buy	+1,592	New	+$227K	﹤0.01%	3865
2018 Q1	–	Sell	-12,857	Closed	-$515K	–	4249
2017 Q4	$515K	Buy	+12,857	New	+$467K	﹤0.01%	3554

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust's ASND Position: Q2 2026 in Review

Northern Trust increased its Ascendis Pharma A/S (ASND) stake by 131% in Q2 2026, buying an estimated $13.8M and bringing the position to 103,933 shares worth $27.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Northern Trust first reported a position in ASND in Q4 2017 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Northern Trust held 103,933 shares of Ascendis Pharma A/S worth $27.7M as of Q2 2026.
Northern Trust bought 58,962 Ascendis Pharma A/S shares in Q2 2026, an estimated $13.8M.
Ascendis Pharma A/S made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1602 holding.
Northern Trust first reported a position in Ascendis Pharma A/S in Q4 2017 and has held it in 6 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.